Collectively, these data suggest that transcription of HERVs and other LTR elements that are highly specific to ccRCC were overexpressed in non-responders pre-treatment and were associated with an absence of ongoing anti-tumor immune responses and lack of response to anti-PD-1. Here, PDCD1 is linked to neoplasm.